[Solved]: A key component of the Mycophenolate REMS programs…

A key component of the Mycophenolate REMS programs is testing patients for pregnancy. The testing frequency described in each REMS is the same, except the PS-Mycophenolate REMS recommends an additional test 6 weeks after ending mycophenolate therapy. Which of the following best describes the recommended pregnancy testing schedule common to both REMS programs? A. Immediately before initiation of mycophenolate therapy, at 8 to 10 days after starting mycophenolate therapy, and at routine follow-up visits B. Immediately before initiation of mycophenolate therapy and at 8 to 10 days after starting mycophenolate therapy C. Immediately before initiation of mycophenolate therapy, at 30 days after starting mycophenolate therapy, and at routine follow-up visits D. Immediately after initiation of mycophenolate therapy, at 8 to 10 days after starting mycophenolate therapy, and at routine follow-up visits